Recent progress in development of dopamine receptor subtype-selective agents: Potential therapeutics for neurological and psychiatric disorders

被引:340
作者
Zhang, Ao [1 ]
Neumeyer, John L.
Baldessarini, Ross J.
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, Bioorgan & Med Chem Lab, Shanghai 201203, Peoples R China
[2] Harvard Univ, Sch Med, McLean Hosp, Med Chem Lab, Belmont, MA 02478 USA
[3] Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02178 USA
[4] Harvard Univ, Sch Med, Program Neurosci, Belmont, MA 02178 USA
[5] McLean Hosp, Neuropharmacol Lab, Belmont, MA 02478 USA
关键词
D O I
10.1021/cr050263h
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
This review covers progress during 2000-2005 on the development of selective ligands targeting mainly to the five main dopamine (DA) receptors. Topics discussed include the pharmacology of dopamine receptor subtypes and the development of dopamine receptor subtype ligands. As for the latter, emphasis is on the receptor-selective ligands from D1 to D4. Generally, recent efforts in medicinal chemistry and neuropharmacology have yielded substantial numbers of compounds with activity and selectivity at each of these major DA receptors.
引用
收藏
页码:274 / 302
页数:29
相关论文
共 254 条
[31]   The role of dopamine in reward and pleasure behaviour - review of data from preclinical research [J].
Bressan, RA ;
Crippa, JA .
ACTA PSYCHIATRICA SCANDINAVICA, 2005, 111 :14-21
[32]   TRANS-10,11-DIHYDROXY-5,6,6A,7,8,12B-HEXAHYDROBENZO[A]PHENANTHRIDINE - A HIGHLY POTENT SELECTIVE DOPAMINE-D1 FULL AGONIST [J].
BREWSTER, WK ;
NICHOLS, DE ;
RIGGS, RM ;
MOTTOLA, DM ;
LOVENBERG, TW ;
LEWIS, MH ;
MAILMAN, RB .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (06) :1756-1764
[33]   Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats [J].
Brioni, JD ;
Moreland, RB ;
Cowart, M ;
Hsieh, GC ;
Stewart, AO ;
Hedlund, P ;
Donnelly-Roberts, DL ;
Nakane, M ;
Lynch, JJ ;
Kolasa, T ;
Polakowski, JS ;
Osinski, MA ;
Marsh, K ;
Andersson, KE ;
Sullivan, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (17) :6758-6763
[34]   BOTH SPLICING VARIANTS OF THE DOPAMINE-D2 RECEPTOR MESSENGERRNA ARE UP-REGULATED BY ANTIPSYCHOTIC-DRUGS [J].
BUCKLAND, PR ;
ODONOVAN, MC ;
MCGUFFIN, P .
NEUROSCIENCE LETTERS, 1993, 150 (01) :25-28
[35]   Synthesis and dopamine receptor selectivity of the benzyltetrahydroisoquinoline, (R)-(+)-nor-roefractine [J].
Cabedo, N ;
Protais, P ;
Cassels, BK ;
Cortes, D .
JOURNAL OF NATURAL PRODUCTS, 1998, 61 (06) :709-712
[36]   Enantioselective syntheses of dopaminergic (R)- and (S)-benzyltetrahydroisoquinolines [J].
Cabedo, N ;
Andreu, I ;
de Arellano, MCR ;
Chagraoui, A ;
Serrano, A ;
Bermejo, A ;
Protais, P ;
Cortes, D .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (11) :1794-1801
[37]   Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents [J].
Campiani, G ;
Butini, S ;
Fattorusso, C ;
Catalanotti, B ;
Gemma, S ;
Nacci, V ;
Morelli, E ;
Cagnotto, A ;
Mereghetti, I ;
Mennini, T ;
Carli, M ;
Minetti, P ;
Di Cesare, MA ;
Mastroianni, D ;
Scafetta, N ;
Galletti, B ;
Stasi, MA ;
Castorina, M ;
Pacifici, L ;
Vertechy, M ;
Di Serio, S ;
Ghirardi, O ;
Tinti, O ;
Carminati, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (01) :143-157
[38]   Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands:: Inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors [J].
Campiani, G ;
Butini, S ;
Trotta, F ;
Fattorusso, C ;
Catalanotti, B ;
Aiello, F ;
Gemma, S ;
Nacci, V ;
Novellino, E ;
Stark, JA ;
Cagnotto, A ;
Fumagalli, E ;
Carnovali, F ;
Cervo, L ;
Mennini, T .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (18) :3822-3839
[39]   Pyrrolo[1,3]benzothiazepine-based atypical antipsychotic agents. Synthesis, structure-activity relationship, molecular modeling, and biological studies [J].
Campiani, G ;
Butini, S ;
Gemma, S ;
Nacci, V ;
Fattorusso, C ;
Catalanotti, B ;
Giorgi, G ;
Cagnotto, A ;
Goegan, M ;
Mennini, T ;
Minetti, P ;
Di Cesare, MA ;
Mastroianni, D ;
Scafetta, N ;
Galletti, B ;
Stasi, MA ;
Castorina, M ;
Pacifici, L ;
Ghirardi, O ;
Tinti, O ;
Carminati, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (02) :344-359
[40]   New antipsychotic agents with serotonin and dopamine antagonist properties based on a pyrrolo[2,1-b][1,3]benzothiazepine structure [J].
Campiani, G ;
Nacci, V ;
Bechelli, S ;
Ciani, SM ;
Garofalo, A ;
Fiorini, I ;
Wikström, H ;
de Boer, P ;
Liao, Y ;
Tepper, PG ;
Cagnotto, A ;
Mennini, T .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (20) :3763-3772